alpha defensin 1 (α-defensin 1) antibody and antigen (Recombinant protein)
Diagnostic alpha defensin 1 (α-defensin 1) antibodies (anti-alpha defensin 1, anti-α-defensin 1) and antigens (recombinant alpha defensin 1 (α-defensin 1) protein) for Inflammation/autoimmune/inflammatory disease α-defensin 1 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-a-defensin-1-Ag01 | Peptide human DEFA1/α-defensin 1/DEF1/DEFA2 protein | 3090 |
GMP-h-a-defensin-1-Ab01 | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-a-defensin-1-Ab02 | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-a-defensin-1-Ab03 | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 human monoclonal antibody (mAb) | 1953 |
GMP-h-a-defensin-1-Ab04 | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-a-defensin-1-Ag01 |
Product Name | Peptide human DEFA1/α-defensin 1/DEF1/DEFA2 protein |
Target/Biomarker | alpha defensin 1(α-defensin 1) |
Alias of Target/Biomarker | DEF1, DEFA2, HNP-1, HP-1, HP1, MRS |
Expression platform | synthesized |
Isotypes | Peptide Antigen |
Bioactivity validation | alpha defensin 1 (α-defensin 1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. |
Products description | Peptide human DEFA1/α-defensin 1/DEF1/DEFA2 protein was expressed in synthesized expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-a-defensin-1-Ab01, GMP-h-a-defensin-1-Ab02 |
Product Name | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 mouse monoclonal antibody (mAb) |
Target/Biomarker | alpha defensin 1(α-defensin 1) |
Alias of Target/Biomarker | DEF1, DEFA2, HNP-1, HP-1, HP1, MRS |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human alpha defensin 1 (α-defensin 1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 1 (α-defensin 1) antibodies in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-a-defensin-1-Ab03, GMP-h-a-defensin-1-Ab04 |
Product Name | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 human monoclonal antibody (mAb) |
Target/Biomarker | alpha defensin 1(α-defensin 1) |
Alias of Target/Biomarker | DEF1, DEFA2, HNP-1, HP-1, HP1, MRS |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human alpha defensin 1 (α-defensin 1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 1 (α-defensin 1) antibodies in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human DEFA1/α-defensin 1/DEF1/DEFA2 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Alpha defensins are a family of mammalian defensin peptides of the alpha subfamily. Prosthetic joint infection (PJI) management is not standardized worldwide. Diagnosis of PJI remains challenging because the clinical signs and symptoms and elevation of systemic biomarkers (C-reactive protein, erythrocyte sedimentation rate) may be unclear. Synovial biomarkers have shown encouraging results and they should be used as diagnostic adjuncts to synovial white cell count and culture bacteriology. Synovial leukocyte esterase (LE) and synovial C-reactive protein (CRP) have been evaluated as good screening measures; however, the most promising synovial fluid biomarker in terms of sensitivity and specificity for PJI seems to be alpha defensin (AD). alpha defensin lateral flow test could have its place in ruling in a suspected PJI intraoperatively because of its high specificity and rapid results.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments